ASERX
Price
$120.27
Change
+$0.51 (+0.43%)
Updated
Aug 21 closing price
Net Assets
6.23B
GFACX
Price
$73.30
Change
+$0.65 (+0.89%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

ASERX vs GFACX

ASERX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
ASERX vs. GFACX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASERX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 342B vs. ASERX (6.23B). ASERX (0.00) and GFACX (0.00) have matching dividends . ASERX was incepted earlier than GFACX: ASERX (21 years) vs GFACX (25 years). ASERX (1.48) is less costly to investors than GFACX (1.35). GFACX is a more actively managed with annual turnover of: 32.00 vs. ASERX (22.00). GFACX has a lower initial minimum investment than ASERX: GFACX (250) vs ASERX (2500). GFACX annual gain was more profitable for investors over the last year : 2.93 vs. ASERX (1.63). GFACX return over 5 years is better than : 7.51 vs. ASERX (6.55).
ASERXGFACXASERX / GFACX
Total Expense Ratio1.401.35104%
Annual Report Gross Expense Ratio1.481.35110%
Fund Existence21 years25 years-
Gain YTD3.2808.91537%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.23B342B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.632.9356%
Returns for 3 years34.9238.5191%
Returns for 5 years6.557.5187%
Returns for 10 years106.6177.91137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBS5.080.26
+5.39%
Emergent Biosolutions
MXL66.611.33
+2.04%
MaxLinear
IART16.740.15
+0.90%
Integra LifeSciences Holdings Corp
BNY158.491.25
+0.79%
Bank of New York Mellon Corp.
CCM5.290.04
+0.76%
Concord Medical Services Holding Limited